Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Fairly rare small-diameter hepatocellular carcinoma with right adrenal gland metastasis having an inferior vena cava tumor thrombus: a case report.

Igarashi T, Harimoto N, Matsumura N, Sugiyama M, Araki K, Yokobori T, Kosone T, Takagi H, Aishima S, Yokoo H, Shirabe K.

Surg Case Rep. 2019 Nov 6;5(1):170. doi: 10.1186/s40792-019-0705-7.

PMID:
31696344
2.

Evaluation of the use of intraoperative real-time virtual sonography with sonazoid enhancement for detecting small liver metastatic lesions after chemotherapy in hepatic resection.

Araki K, Harimoto N, Muranushi R, Hoshino K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shirabe K.

J Med Invest. 2019;66(3.4):319-323. doi: 10.2152/jmi.66.319.

3.

FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.

Watanabe A, Harimoto N, Yokobori T, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Handa T, Oyama T, Higuchi T, Shirabe K.

Int J Clin Oncol. 2019 Oct 14. doi: 10.1007/s10147-019-01557-0. [Epub ahead of print]

PMID:
31612350
4.

The evolution of surgical treatment for gastrointestinal cancers.

Maehara Y, Soejima Y, Yoshizumi T, Kawahara N, Oki E, Saeki H, Akahoshi T, Ikegami T, Yamashita YI, Furuyama T, Sugimachi K, Harada N, Tagawa T, Harimoto N, Itoh S, Sonoda H, Ando K, Nakashima Y, Nagao Y, Yamashita N, Kasagi Y, Yukaya T, Kurihara T, Tsutsumi R, Takamori S, Sasaki S, Ikeda T, Yonemitsu Y, Fukuhara T, Kitao H, Iimori M, Kataoka Y, Wakasa T, Suzuki M, Teraishi K, Yoshida Y, Mori M.

Int J Clin Oncol. 2019 Nov;24(11):1333-1349. doi: 10.1007/s10147-019-01499-7. Epub 2019 Sep 14.

PMID:
31522313
5.

Global standardization of laparoscopic liver resection and challenges for the future.

Araki K, Harimoto N, Shirabe K.

Hepatobiliary Surg Nutr. 2019 Aug;8(4):386-388. doi: 10.21037/hbsn.2019.02.08. No abstract available.

6.

Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment.

Araki K, Harimoto N, Kubo N, Watanabe A, Igarashi T, Tsukagoshi M, Ishii N, Tsushima Y, Shirabe K.

HPB (Oxford). 2019 Aug 30. pii: S1365-182X(19)30687-2. doi: 10.1016/j.hpb.2019.08.002. [Epub ahead of print]

PMID:
31477460
7.

Optimal indications for an intercostal port for the superior segments in laparoscopic partial liver resection.

Araki K, Harimoto N, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shirabe K.

Asian J Endosc Surg. 2019 Aug 29. doi: 10.1111/ases.12753. [Epub ahead of print]

PMID:
31468734
8.

High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.

Hagiwara K, Harimoto N, Yokobori T, Muranushi R, Hoshino K, Gantumur D, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Shirabe K.

Ann Surg Oncol. 2019 Aug 28. doi: 10.1245/s10434-019-07708-x. [Epub ahead of print]

PMID:
31463696
9.

Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages.

Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K.

Pancreatology. 2019 Sep;19(6):897-902. doi: 10.1016/j.pan.2019.08.003. Epub 2019 Aug 7.

PMID:
31409525
10.

Preoperative Mac-2 binding protein glycosylation isomer level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma.

Ishii N, Harimoto N, Araki K, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Yamanaka T, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Shirabe K.

Hepatol Res. 2019 Jul 24. doi: 10.1111/hepr.13412. [Epub ahead of print]

PMID:
31339606
11.

Impact of skeletal muscle mass volume on surgical site infection in free flap reconstruction for oral cancer.

Makiguchi T, Yamaguchi T, Nakamura H, Suzuki K, Harimoto N, Shirabe K, Yokoo S.

Microsurgery. 2019 Oct;39(7):598-604. doi: 10.1002/micr.30494. Epub 2019 Jul 22.

PMID:
31328303
12.

Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor.

Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K.

Pancreas. 2019 Aug;48(7):943-947. doi: 10.1097/MPA.0000000000001355.

PMID:
31268980
13.

Peritransplant kinetics of Mac-2-binding protein glycosylation isomer levels in living donor liver transplantation: its implication of posttransplant small-for-size syndrome.

Uchiyama H, Shirabe K, Bekki Y, Toshima T, Harimoto N, Ikegami T, Yoshizumi T.

Transl Gastroenterol Hepatol. 2019 May 25;4:41. doi: 10.21037/tgh.2019.05.08. eCollection 2019.

14.

Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation.

Ikegami T, Yoshizumi T, Harimoto N, Mori M.

Liver Transpl. 2019 Aug;25(8):1281-1283. doi: 10.1002/lt.25494. Epub 2019 Jul 2. No abstract available.

PMID:
31106497
15.

Evaluation of KRAS Mutation Status in a Patient With Concomitant Pancreatic Neuroendocrine Neoplasm and Intraductal Papillary Mucinous Neoplasm.

Igarashi T, Harimoto N, Nobusawa S, Yoshida Y, Yamanaka T, Hagiwara K, Hoshino K, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Araki K, Yokobori T, Yokoo H, Shirabe K.

Pancreas. 2019 May/Jun;48(5):e34-e35. doi: 10.1097/MPA.0000000000001286. No abstract available.

PMID:
31090662
16.

Hepatic pleomorphic leiomyosarcoma after surgery for gastric gastrointestinal stromal tumor: a case report.

Muranushi R, Hoshino K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Harimoto N, Ikota H, Shibuya K, Miyazaki M, Shirabe K.

Surg Case Rep. 2019 Apr 16;5(1):62. doi: 10.1186/s40792-019-0622-9.

17.

Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report.

Hoshino K, Harimoto N, Muranushi R, Araki K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Yokobori T, Shirabe K.

Surg Case Rep. 2019 Apr 10;5(1):56. doi: 10.1186/s40792-019-0619-4.

18.

Impact of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma.

Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Tomonaga H, Higuchi T, Tsushima Y, Shirabe K.

Anticancer Res. 2019 Feb;39(2):971-977. doi: 10.21873/anticanres.13201.

PMID:
30711983
19.

Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma.

Watanabe A, Harimoto N, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Yoshizumi T, Shirabe K.

Anticancer Res. 2019 Feb;39(2):941-947. doi: 10.21873/anticanres.13197.

PMID:
30711979
20.

Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse Liver.

Harimoto N, Nakagawara H, Shirabe K, Yoshizumi T, Itoh S, Ikegami T, Soejima Y, Maehara Y, Ishida Y, Tateno C, Tanaka Y.

Transplant Proc. 2018 Dec;50(10):3858-3862. doi: 10.1016/j.transproceed.2018.06.035. Epub 2018 Jun 30.

PMID:
30577278
21.

Real-Time Ultrasound-Guided Thrombectomy for Extensive Portal Vein Thrombosis in Living Donor Liver Transplantation.

Soejima Y, Yoshizumi T, Ikegami T, Harimoto N, Harada N, Itoh S, Toshima T, Motomura T, Mano Y, Ohira M, Bekki Y, Maehara Y.

Transplant Proc. 2018 Dec;50(10):3549-3551. doi: 10.1016/j.transproceed.2018.08.047. Epub 2018 Sep 6.

PMID:
30577235
22.

Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.

Ishii N, Araki K, Yokobori T, Hagiwara K, Gantumur D, Yamanaka T, Handa T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Harimoto N, Masamune A, Umezawa K, Kuwano H, Shirabe K.

Cancer Sci. 2019 Jan;110(1):334-344. doi: 10.1111/cas.13847. Epub 2018 Dec 13.

23.

Slow Gait Speed Is a Risk Factor for Complications After Hepatic Resection.

Itoh S, Yoshizumi T, Sakata K, Motomura T, Mano Y, Toshima T, Harimoto N, Harada N, Ikegami T, Soejima Y, Kusaba R, Kamishima T, Nishie A, Maehara Y.

J Gastrointest Surg. 2019 Sep;23(9):1810-1816. doi: 10.1007/s11605-018-3993-5. Epub 2018 Oct 8.

PMID:
30298420
24.

A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.

Watanabe A, Harimoto N, Araki K, Yoshizumi T, Arima K, Yamashita Y, Baba H, Tetsuya H, Kuwano H, Shirabe K.

J Surg Oncol. 2018 Dec;118(7):1088-1095. doi: 10.1002/jso.25250. Epub 2018 Sep 27.

PMID:
30261101
25.

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma.

Okabe H, Yoshizumi T, Yamashita YI, Imai K, Hayashi H, Nakagawa S, Itoh S, Harimoto N, Ikegami T, Uchiyama H, Beppu T, Aishima S, Shirabe K, Baba H, Maehara Y.

PLoS One. 2018 Sep 14;13(9):e0203856. doi: 10.1371/journal.pone.0203856. eCollection 2018.

26.

The Feature of Solitary Small Nodular Type of Hepatic Epithelioid Hemangioendothelioma.

Kubo N, Harimoto N, Araki K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Miyazaki M, Yokoo H, Kuwano H, Shirabe K.

Case Rep Gastroenterol. 2018 Aug 21;12(2):402-410. doi: 10.1159/000490524. eCollection 2018 May-Aug.

27.

Fairly rare clear cell adenocarcinoma mimicking liver cancer: a case report.

Harimoto N, Hagiwara K, Yamanaka T, Ishii N, Igarashi T, Watanabe A, Kubo N, Araki K, Ikota H, Suyama M, Maki T, Aishima S, Kuwano H, Shirabe K.

Surg Case Rep. 2018 Aug 16;4(1):97. doi: 10.1186/s40792-018-0500-x.

28.

Skeletal Muscle Volume and Intramuscular Adipose Tissue Are Prognostic Predictors of Postoperative Complications After Hepatic Resection.

Harimoto N, Hoshino H, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Shirabe K.

Anticancer Res. 2018 Aug;38(8):4933-4939. doi: 10.21873/anticanres.12810.

PMID:
30061272
29.

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.

Harimoto N, Yoshizumi T, Inokuchi S, Itoh S, Adachi E, Ikeda Y, Uchiyama H, Utsunomiya T, Kajiyama K, Kimura K, Kishihara F, Sugimachi K, Tsujita E, Ninomiya M, Fukuzawa K, Maeda T, Shirabe K, Maehara Y.

Ann Surg Oncol. 2018 Oct;25(11):3316-3323. doi: 10.1245/s10434-018-6672-6. Epub 2018 Jul 26.

PMID:
30051372
30.

Multiple hepatic sclerosing hemangiomas: a case report and review of the literature.

Yugawa K, Yoshizumi T, Harada N, Motomura T, Harimoto N, Itoh S, Ikegami T, Soejima Y, Maehara Y.

Surg Case Rep. 2018 Jun 19;4(1):60. doi: 10.1186/s40792-018-0468-6.

31.

Successful treatment of isolated bile leakage after hepatectomy combination therapy with percutaneous transhepatic portal embolization and bile duct ablation with ethanol: a case report.

Kubo N, Harimoto N, Shibuya K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Araki K, Miyazaki M, Kuwano H, Shirabe K.

Surg Case Rep. 2018 Jun 19;4(1):61. doi: 10.1186/s40792-018-0463-y.

32.

High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma.

Shimoda Y, Ubukata Y, Handa T, Yokobori T, Watanabe T, Gantumur D, Hagiwara K, Yamanaka T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Harimoto N, Katayama A, Hikino T, Sano T, Ogata K, Kuwano H, Shirabe K, Oyama T.

BMC Cancer. 2018 May 25;18(1):597. doi: 10.1186/s12885-018-4503-6.

33.

Resected primary mucinous cholangiocarcinoma of the liver.

Hagiwara K, Araki K, Yamanaka T, Ishii N, Igarashi T, Watanabe A, Kubo N, Harimoto N, Kuwano H, Nobusawa S, Aishima S, Shirabe K.

Surg Case Rep. 2018 May 2;4(1):41. doi: 10.1186/s40792-018-0450-3.

34.

Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case report.

Takayoshi K, Doi G, Tsuruta N, Yoshihiro T, Nio K, Tsuchihashi K, Ariyama H, Odawara J, Shimoda S, Kohashi K, Oda Y, Itoh S, Harimoto N, Maehara Y, Kusaba H, Akashi K, Baba E.

Medicine (Baltimore). 2018 Apr;97(15):e0378. doi: 10.1097/MD.0000000000010378.

35.

D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.

Watanabe A, Araki K, Harimoto N, Kubo N, Igarashi T, Ishii N, Yamanaka T, Hagiwara K, Kuwano H, Shirabe K.

Int J Clin Oncol. 2018 Aug;23(4):689-697. doi: 10.1007/s10147-018-1271-x. Epub 2018 Mar 24.

PMID:
29574651
36.

High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.

Suzuki K, Watanabe A, Araki K, Yokobori T, Harimoto N, Gantumur D, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Kubo N, Gombodorj N, Nishiyama M, Hosouchi Y, Kuwano H, Shirabe K.

Anticancer Res. 2018 Feb;38(2):939-944.

PMID:
29374725
37.

Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.

Harimoto N, Yoshizumi T, Fujimoto Y, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

World J Surg. 2018 Aug;42(8):2606-2616. doi: 10.1007/s00268-018-4493-1.

PMID:
29372372
38.

The impact of donor liver allograft fibrosis on patients undergoing liver transplantation.

Wadhera V, Harimoto N, Lubezky N, Gomatos I, Facciuto M, Gonzalez D, Stueck A, Fiel MI, Schiano T, Facciuto ME.

Clin Transplant. 2018 Mar;32(3):e13187. doi: 10.1111/ctr.13187. Epub 2018 Feb 11.

PMID:
29314293
39.

Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.

Harimoto N, Yugawa K, Ikegami T, Ohira M, Mano Y, Motomura T, Toshima T, Itoh S, Harada N, Soejima Y, Yoshizumi T, Maehara Y, Oda Y.

J Gastroenterol Hepatol. 2018 Jan;33(1):9. doi: 10.1111/jgh.13975. No abstract available.

PMID:
29284078
40.

Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.

Motomura T, Yoshizumi T, Ohira M, Mano Y, Toshima T, Itoh S, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Transplant Proc. 2017 Dec;49(10):2409-2410. doi: 10.1016/j.transproceed.2017.09.014.

PMID:
29198692
41.

Potential effect of recombinant thrombomodulin on ischemia-reperfusion liver injury in rats.

Kimura K, Yoshizumi T, Inokuchi S, Itoh S, Motomura T, Mano Y, Toshima T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Hepatol Res. 2018 Apr;48(5):391-396. doi: 10.1111/hepr.13005. Epub 2018 Jan 8.

PMID:
29168258
42.

Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.

Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, Ikegami T, Uchiyama H, Soejima Y, Nishie A, Kamishima T, Kusaba R, Shirabe K, Maehara Y.

Transplant Proc. 2017 Nov;49(9):2144-2152. doi: 10.1016/j.transproceed.2017.09.017.

PMID:
29149975
43.

MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection.

Shimagaki T, Yoshizumi T, Harimoto N, Yoshio S, Naito Y, Yamamoto Y, Ochiya T, Yoshida Y, Kanto T, Maehara Y.

Hepatol Res. 2018 Mar;48(4):313-321. doi: 10.1111/hepr.12990. Epub 2017 Dec 5.

PMID:
28984009
44.

Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Takeishi K, Kawanaka H, Itoh S, Harimoto N, Ikegami T, Yoshizumi T, Shirabe K, Maehara Y.

World J Surg. 2018 Apr;42(4):1120-1128. doi: 10.1007/s00268-017-4232-z.

PMID:
28920178
45.

Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years.

Uchiyama H, Itoh S, Yoshizumi T, Ikegami T, Harimoto N, Soejima Y, Harada N, Morita K, Toshima T, Motomura T, Maehara Y.

HPB (Oxford). 2017 Dec;19(12):1082-1090. doi: 10.1016/j.hpb.2017.08.004. Epub 2017 Sep 7.

46.

The prevalence of transpancreatic common hepatic artery and coexisting variant anatomy.

Ishigami K, Nishie A, Asayama Y, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Yoshizumi T, Harimoto N, Ohtsuka T, Nakata K, Honda H.

Clin Anat. 2018 May;31(4):598-604. doi: 10.1002/ca.22957. Epub 2017 Dec 8.

PMID:
28726321
47.

Associations between antibody to hepatitis B core antigen positivity and outcomes in hepatocellular carcinoma patients undergoing hepatic resection.

Itoh S, Yoshizumi T, Tomino T, Nagatsu A, Motomura T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Hepatol Res. 2018 Feb;48(3):E155-E161. doi: 10.1111/hepr.12939. Epub 2017 Sep 28.

PMID:
28710825
48.

Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.

Harada N, Yoshizumi T, Yamashita YI, Soejima Y, Ikegami T, Harimoto N, Itoh S, Maehara Y.

Anticancer Res. 2017 Jul;37(7):3763-3769.

PMID:
28668872
49.

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Harimoto N, Yoshizumi T, Sakata K, Nagatsu A, Motomura T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

World J Surg. 2017 Nov;41(11):2805-2812. doi: 10.1007/s00268-017-4097-1.

PMID:
28653142
50.

Customization of laparoscopic gastric devascularization and splenectomy for gastric varices based on CT vascular anatomy.

Kawanaka H, Akahoshi T, Nagao Y, Kinjo N, Yoshida D, Matsumoto Y, Harimoto N, Itoh S, Yoshizumi T, Maehara Y.

Surg Endosc. 2018 Jan;32(1):114-126. doi: 10.1007/s00464-017-5646-2. Epub 2017 Jun 21.

PMID:
28639036

Supplemental Content

Loading ...
Support Center